AbbVie (ABBV) Intangibles (2012 - 2026)

AbbVie has disclosed Intangibles across 15 years of filings, most recently posting $50.9 billion for Q1 2026.

• In Q1 2026, Intangibles fell 13.02% year-over-year to $50.9 billion; the TTM figure through Mar 2026 stood at $50.9 billion (down 13.02% YoY), while the FY2025 annual figure was $52.6 billion, down 12.36% from the prior year.
• Intangibles retreated to $50.9 billion in Q1 2026, from $52.6 billion in the prior quarter.
• Over the last five years, Intangibles for ABBV reached as high as $74.0 billion in Q1 2022 and fell as low as $711.0 million in Q3 2025.
• The 5-year median for Intangibles is $60.2 billion (2024), against an average of $58.4 billion.
• Annual changes were most pronounced in 2024 — Intangibles grew 13.72% — and 2025, when it slumped 98.93%.
• A 5-year view of Intangibles shows it stood at $67.4 billion in 2022, then dropped by 17.54% to $55.6 billion in 2023, then grew by 8.02% to $60.1 billion in 2024, then slipped by 12.36% to $52.6 billion in 2025, then fell by 3.36% to $50.9 billion in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $50.9 billion, $52.6 billion, and $711.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.